Sorafenib induces apoptosis of MM cell lines and primary CD138+ MM cells via caspase-dependent and caspase-independent mechanisms in the presence of BMSCs, thus abrogating the protective effect of the BM milieu. The gene discussed is SDC1; the disease is Miyoshi myopathy.